These findings were corroborated by our observation that the putative Chemerin receptor, CCRL2, was remarkably upregulated in cSCC tumor cells, which, together with the GPR1 receptor, mediated the response to Chemerin. This evidence concerns the gene RARRES2 and skin squamous cell carcinoma.